The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Prospective, Randomized Comparison of Effect of Long-Term Treatment With Metoprolol or Carvedilol on Symptoms, Exercise, Ejection Fraction, and Oxidative Stress in Heart Failure
Abstract
Background—With β-blocker use becoming more prevalent in treating chronic heart failure (CHF), the choice of drugs raises important theoretical and practical questions. Although the second-generation compound metoprolol is β 1-selective, the third-generation compound carvedilol is β-nonselective, with ancillary pharmacological properties including α-blockade and antioxidant effects. A prospective comparison of these 2 agents can address the issue of optimal adrenergic blockade in selecting agents for therapy in CHF. Methods and Results—Sixty-seven patients with symptomatic stable heart failure were randomly assigned to receive either carvedilol or metoprolol in addition to standard therapy for CHF. Measured variables included symptoms, exercise, ejection fraction, and thiobarbituric acid–reactive substances (TBARS) as an indirect marker of free radical activity. Metoprolol and carvedilol were well tolerated, and both patient groups showed beneficial effects of β-blocker therapy in each of the measured parameters, with no between-group differences. Ejection fraction increased over 6 months from 18±6.3% to 23±8.7% (P<0.005) with metoprolol and from 19±8.5% to 25±9.9% (P<0.0005) with carvedilol (P=NS between groups). With metoprolol, TBARS values decreased from 4.7±0.9 nmol/mL at baseline to 4.2±1.5 nmol/mL at month 4 to 3.9±1.0 nmol/mL at month 6 (P<0.0001). With carvedilol, there was a parallel decline from 4.7±1.4 to 4.2±1.3 to 4.1±1.2 nmol/mL over the same time frame (P<0.025), with no between-group difference in these changes. Conclusions—Carvedilol and metoprolol showed parallel beneficial effects in the measured parameters over 6 months, with no relevant between-group differences in this heart failure population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.
Guyatt, G. H., Sullivan, M. J., Thompson, P. J., Fallen, E. L., Pugsley, S. O., Taylor, D. W., & Berman, L. (1985) · Europe PMC (PubMed Central) · Cited by 2,401
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Handbook of methods for oxygen radical research
Greenwald, R. A. (1987) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(87)80012-6 · Cited by 2,381
Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method
Kei, S. (1978) · Clinica Chimica Acta · doi:10.1016/0009-8981(78)90081-5 · Cited by 1,725
Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method
佐藤, 敬. (1979) · Medical Entomology and Zoology · Cited by 1,518
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Waagstein, F., Hjalmarson, A., Swedberg, K., Bristow, M. R., Gilbert, E. M., Camerini, F., Fowler, M. B., Silver, M. A., Johnson, M. R., & Goss, F. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)92930-r · Cited by 1,234
Patients' self-assessment of their congestive heart failure
Ts, R. (1987) · Medical Entomology and Zoology · Cited by 1,020
The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters
Dahle, L. K., Hill, E. G., & Holman, R. T. (1962) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(62)90181-9 · Cited by 839
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
Waagstein, F., Hjalmarson, A., Varnauskas, E., & Wallentin, I. (1975) · Heart · doi:10.1136/hrt.37.10.1022 · Cited by 832
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
Colucci, W. S., Packer, M., Bristow, M. R., Gilbert, E. M., Cohn, J. N., Fowler, M. B., Krueger, S. K., Hershberger, R., Uretsky, B. F., Bowers, J. A., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2800 · Cited by 635
Fowler, M. B., Laser, J. A., Hopkins, G. L., Minobe, W., & Bristow, M. R. (1986) · Circulation · doi:10.1161/01.cir.74.6.1290 · Cited by 562
Oxygen free radicals and congestive heart failure.
Belch, J. J., Bridges, A. B., Scott, N., & Chopra, M. (1991) · Heart · doi:10.1136/hrt.65.5.245 · Cited by 550
Yue, T. L., Cheng, H. Y., Lysko, P. G., McKenna, P. J., Feuerstein, R., Gu, J. L., Lysko, K. A., Davis, L. L., & Feuerstein, G. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10363-7 · Cited by 485
Gilbert, E. M., Abraham, W. T., Olsen, S., Hattler, B., White, M., Mealy, P., Larrabee, P., & Bristow, M. R. (1996) · Circulation · doi:10.1161/01.cir.94.11.2817 · Cited by 442
Heilbrunn, S. M., Shah, P., Bristow, M. R., Valantine, H. A., Ginsburg, R., & Fowler, M. B. (1989) · Circulation · doi:10.1161/01.cir.79.3.483 · Cited by 427
Cardiopulmonary exercise testing for evaluation of chronic cardiac failure
Weber, K. T., & Janicki, J. S. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90792-1 · Cited by 374
Krum, H., Sackner-Bernstein, J. D., Goldsmith, R. L., Kukin, M. L., Schwartz, B., Penn, J., Medina, N., Yushak, M., Horn, E., Katz, S. D., et al. (1995) · Circulation · doi:10.1161/01.cir.92.6.1499 · Cited by 374
Self-citationOlsen, S. L., Gilbert, E. M., Renlund, D. G., Taylor, D. O., Yanowitz, F. D., & Bristow, M. R. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00012-s · Cited by 373
Metra, M., Nardi, M., Giubbini, R., & Cas, L. D. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90174-0 · Cited by 320
Dulin, B., & Abraham, W. T. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.003 · Cited by 311
Giugliano, D., Acampora, R., Marfella, R., De Rosa, N., Ziccardi, P., Ragone, R., De Angelis, L., & D'Onofrio, F. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00004 · Cited by 302
HJALMARSON, A., FAGERBERG, S. G. B., WREDEL, H., WAAGSTEIN, F., KJEKSHUS, J., WIKSTRAND, J., EL ALLAF, D., VÍTOVEC, J., ALDERSHIVILE, J., HALINEN, M., et al. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200012000-00023 · Cited by 282
Evidence of oxidative stress in chronic heart failure in humans
McMURRAY, J., CHOPRA, M., ABDULLAH, I., SMITH, W. E., & DARGIE, H. J. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.11.1493 · Cited by 278
Packer, M., Meller, J., Gorlin, R., & Herman, M. V. (1979) · Circulation · doi:10.1161/01.cir.59.3.531 · Cited by 241
The pharmacology of carvedilol
Ruffolo, R. R., Gellai, M., Hieble, J. P., Willette, R. N., & Nichols, A. J. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf01409471 · Cited by 209
Cardiac adrenergic receptor effects of carvedilol
Yoshikawa, T., Port, J. D., Asano, K., Chidiak, P., Bouvier, M., Dutcher, D., Roden, R. L., Minobe, W., Tremmel, K. D., & Bristow, M. R. (1996) · European Heart Journal · doi:10.1093/eurheartj/17.suppl_b.8 · Cited by 174
Witting, L. A. (1965) · Journal of the American Oil Chemists' Society · doi:10.1007/bf02632443 · Cited by 159
McMurray, J. J. V., McLay, J., Chopra, M., Bridges, A., & Belch, J. J. F. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90985-a · Cited by 140
Kukin, M. L., Kalman, J., Mannino, M. M., Freudenberger, R. S., Buchholz-Varley, C., & Ocampo, O. N. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89342-3 · Cited by 44
Self-citationHeart Failure Therapy in Evolution
Chatterjee, K. (1996) · Circulation · doi:10.1161/01.cir.94.11.2689 · Cited by 35
Cited by
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161
β-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
Role of Oxidative Stress in Myocardial Hypertrophy and Failure
Sawyer, D. B., Siwik, D. A., Xiao, L., Pimentel, D. R., Singh, K., & Colucci, W. S. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.1526 · Cited by 571
(2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.002 · Cited by 557
Greater Oxidative Stress in Healthy Young Men Compared With Premenopausal Women
Ide, T., Tsutsui, H., Ohashi, N., Hayashidani, S., Suematsu, N., Tsuchihashi, M., Tamai, H., & Takeshita, A. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.104515 · Cited by 356
Metadata
- Authors
- Kukin, M. L., Kalman, J., Charney, R. H., Levy, D. K., Buchholz-Varley, C., Ocampo, O. N., & Eng, C.
- Venue
- Circulation
- Published
- 1999-05-25
- Volume
- 99
- Issue
- 20
- Pages
- 2645-2651
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2040815912
- Cited by
- 285
- References
- 33
- FWCI
- 21.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.